Second patient in the world receives Moderna mRNA trial infusion at UTHealth Houston for glycogen storage disease
August 31, 2022
August 31, 2022
HOUSTON, Texas, Aug. 31 (TNSres) -- The University of Texas Health Science Center at Houston issued the following news:
Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose prod . . .
Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose prod . . .